Author pages are created from data sourced from our academic publisher partnerships and public sources.
Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data
- A. Martineau, David A Jolliffe, +22 authors C. Camargo
- British Medical Journal
- 15 February 2017
Objectives To assess the overall effect of vitamin D supplementation on risk of acute respiratory tract infection, and to identify factors modifying this effect. Design Systematic review and… Expand
Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results…
- T. Vesikari, S. Esposito, R. Prymula, E. Ypma, for the EU Meningococcal B Infant Vaccine Study group
- The Lancet
- 9 March 2013
BACKGROUND Meningococcal serogroup B disease disproportionately affects infants. We assessed lot-to-lot consistency, safety and immunogenicity, and the effect of concomitant vaccination on responses… Expand
ESCMID guideline: diagnosis and treatment of acute bacterial meningitis.
- D. van de Beek, C. Cabellos, +11 authors M. C. Brouwer
- Clinical microbiology and infection : the…
- 1 May 2016
D. van de Beek, C. Cabellos, O. Dzupova, S. Esposito, M. Klein, A. T. Kloek, S. L. Leib, B. Mourvillier, C. Ostergaard, P. Pagliano, H. W. Pfister, R. C. Read, O. Resat Sipahi and M. C. Brouwer, for… Expand
Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections
- S. Ashkenazi, André Vertruyen, +11 authors Bruce D. Forrest
- The Pediatric infectious disease journal
- 1 October 2006
Background: Young children have a high incidence of influenza and influenza-related complications. This study compared the efficacy and safety of cold-adapted influenza vaccine, trivalent (CAIV-T)… Expand
Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine Compared to Those of a 7-Valent Pneumococcal Conjugate Vaccine Given as a Three-Dose Series with Routine Vaccines in Healthy…
ABSTRACT A 13-valent pneumococcal conjugate vaccine (PCV13) has been developed to improve protection against pneumococcal disease beyond that possible with the licensed 7-valent vaccine (PCV7). This… Expand
Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection.
Although the clinical relevance of antibiotic treatment in influencing the natural course of Mycoplasma pneumoniae-associated respiratory diseases is questioned by some physicians, most experts… Expand
Characteristics and Their Clinical Relevance of Respiratory Syncytial Virus Types and Genotypes Circulating in Northern Italy in Five Consecutive Winter Seasons
In order to investigate the genetic diversity and patterns of the co-circulating genotypes of respiratory syncytial virus (RSV) and their possible relationships with the severity of RSV infection, we… Expand
Impact of human coronavirus infections in otherwise healthy children who attended an emergency department†
This prospective clinical and virological study of 2,060 otherwise healthy children aged <15 years of age (1,112 males; mean age ± SD, 3.46 ± 3.30 years) who attended the Emergency Department of… Expand
Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and management
BackgroundRubinstein-Taybi syndrome (RSTS) is an extremely rare autosomal dominant genetic disease, with an estimated prevalence of one case per 125,000 live births. RSTS is characterized by typical… Expand
Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants.
We assessed the immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine (PCV7) administered three, five and 11 months post-natally to 46 pre-term (PT) and 46 full-term… Expand